Effect of Celliant Materials on Pain and Blood Oxygenation in Subjects With Chronic Elbow and Wrist Pain

Southern California Institute for Research and Education

Status: Terminated

Conditions: Chronic Elbow Pain; Chronic Wrist Pain

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00688220

#887

Details and patient eligibility

About

The purpose of this research is to determine whether a new type of fabric, Celliant, can reduce elbow and wrist pain associated with chronic medical conditions such as carpel tunnel syndrome, arthritis or tennis elbow and whether it can increase blood flow and oxygenation levels in the arms and hands after wearing the material.

Full description

A new type of fabric, Celliant, is made from polymer yarns containing optically active particles (1-1.2 micron diameter titanium dioxide, quarts and aluminum oxide particles) with modify absorption, reflection and transmission of light in the visible and near infrared portion of the spectrum. It is believed that the Celliant particles increase skin illumination such taht cytochrome pigments and other enzymes are activated, leading to increased blood flow and oxygenation of the skin and neighboring soft tissues. In addition, numerous anecdotal reports from patients with chronic foot and arm pain indicate that wearing Celliant garments for even a few days leads to dramatic improvement in many different painful conditions. This is a single center, stratified, randomized, prospective, double-blind study. Questionnaires that subjects will be asked complete are 1) Visual Analog Scale, 2) Brief Pain Inventory, 3) McGill Short Form Pain Survey and 4) SF-36 Quality of Life Inventory.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic pain for a minimum of 6 months
• A score of equal to or greater than 3 on question III of McGill Short Form Pain Questionnaire

Exclusion criteria

• Open wounds on the involved limb
• Threatened limb loss from ischemia
• Changes in pain or inflammatory medication within the last 30 days
• Psychiatric or other conditions that would affect compliance
• Inability to comply with use of the study articles or to fill out questionnaires

Trial design

0 participants in 2 patient groups

1

Description:

Those wearing garments fabricated with Celliant

2

Description:

Those not wearing garments fabricated using Celliant (placebo).